Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ALITRETINOIN
(1999)
Small molecule
Retinoid receptor agonist
TOPICAL
Approved
Eczema; Neoplasms
ALITRETINOIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
1UA8E65KDZ
Molecule Type:
Small molecule
Molecular Formula:
C20H28O2
Molecular Weight:
300.44
AlogP:
5.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RABEPRAZOLE SODIUM
(1999)
Small molecule
Potassium-transporting ATPase inhibitor
Unknown
Approved
Duodenal Ulcer; Gastroesophageal Reflux; Zollinger-Ellison Syndrome
RABEPRAZOLE SODIUM
×
Maximum Phase:
4
First Approval:
1999
UNII:
3L36P16U4R
Molecule Type:
Small molecule
Molecular Formula:
C18H20N3NaO3S
Molecular Weight:
381.43
AlogP:
2.99
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ZALEPLON
(1999)
Small molecule
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
ORAL
Approved
Sleep Initiation and Maintenance Disorders
ZALEPLON
×
Maximum Phase:
4
First Approval:
1999
UNII:
S62U433RMH
Molecule Type:
Small molecule
Molecular Formula:
C17H15N5O
Molecular Weight:
305.34
AlogP:
2.64
PSA:
74.29
HBD:
0.0
HBA:
#RotB:
3.0
Source:
KETOTIFEN
(1999)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity
KETOTIFEN
×
Maximum Phase:
4
First Approval:
1999
UNII:
X49220T18G
Molecule Type:
Small molecule
Molecular Formula:
C19H19NOS
Molecular Weight:
309.43
AlogP:
4.01
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PIOGLITAZONE
(1999)
Small molecule
Unknown
Unknown
Approved
Diabetes Mellitus
PIOGLITAZONE
×
Maximum Phase:
4
First Approval:
1999
UNII:
X4OV71U42S
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3S
Molecular Weight:
356.45
AlogP:
3.16
PSA:
68.29
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TEMOZOLOMIDE
(1999)
Small molecule
DNA inhibitor
INTRAVENOUS; ORAL
Approved
Glioblastoma; Neoplasms
TEMOZOLOMIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
YF1K15M17Y
Molecule Type:
Small molecule
Molecular Formula:
C6H6N6O2
Molecular Weight:
194.15
AlogP:
-2.08
PSA:
108.17
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ESTROGENS, CONJUGATED SYNTHETIC A
(1999)
Small molecule
Estrogen receptor agonist
ORAL; VAGINAL
Approved
Unknown
ESTROGENS, CONJUGATED SYNTHETIC A
×
Maximum Phase:
4
First Approval:
1999
UNII:
JM2621P2LS
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEXAROTENE
(1999)
Small molecule
Retinoid X receptor agonist
ORAL; TOPICAL
Approved
Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Neoplasms
BEXAROTENE
×
Maximum Phase:
4
First Approval:
1999
UNII:
A61RXM4375
Molecule Type:
Small molecule
Molecular Formula:
C24H28O2
Molecular Weight:
348.49
AlogP:
6.1
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
3.0
Source:
KETOTIFEN FUMARATE
(1999)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Unknown
KETOTIFEN FUMARATE
×
Maximum Phase:
4
First Approval:
1999
UNII:
HBD503WORO
Molecule Type:
Small molecule
Molecular Formula:
C23H23NO5S
Molecular Weight:
425.51
AlogP:
4.01
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
0.0
Source:
LEVETIRACETAM
(1999)
Small molecule
Synaptic vesicle glycoprotein 2A modulator
INTRAVENOUS; ORAL
Approved
Epilepsy; Epilepsy, Tonic-Clonic; Seizures
LEVETIRACETAM
×
Maximum Phase:
4
First Approval:
1999
UNII:
44YRR34555
Molecule Type:
Small molecule
Molecular Formula:
C8H14N2O2
Molecular Weight:
170.21
AlogP:
-0.13
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
OSELTAMIVIR
(1999)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
OSELTAMIVIR
×
Maximum Phase:
4
First Approval:
1999
UNII:
20O93L6F9H
Molecule Type:
Small molecule
Molecular Formula:
C16H28N2O4
Molecular Weight:
312.41
AlogP:
1.29
PSA:
90.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MOXIFLOXACIN
(1999)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections; Eye Infections
MOXIFLOXACIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
U188XYD42P
Molecule Type:
Small molecule
Molecular Formula:
C21H24FN3O4
Molecular Weight:
401.44
AlogP:
2.37
PSA:
83.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AMINOLEVULINIC ACID HYDROCHLORIDE
(1999)
Small molecule
DNA inhibitor
ORAL; TOPICAL
Approved
Unknown
AMINOLEVULINIC ACID HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
V35KBM8JGR
Molecule Type:
Small molecule
Molecular Formula:
C5H10ClNO3
Molecular Weight:
167.59
AlogP:
-0.62
PSA:
80.39
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PEMIROLAST POTASSIUM
(1999)
Small molecule
Unknown
OPHTHALMIC
Approved
Unknown
PEMIROLAST POTASSIUM
×
Maximum Phase:
4
First Approval:
1999
UNII:
497A17OUUE
Molecule Type:
Small molecule
Molecular Formula:
C10H7KN6O
Molecular Weight:
266.31
AlogP:
0.18
PSA:
88.83
HBD:
1.0
HBA:
#RotB:
1.0
Source:
GATIFLOXACIN
(1999)
Small molecule
DNA gyrase inhibitor
OPHTHALMIC
Approved
Bacterial Infections; Conjunctivitis, Bacterial; Eye Infections; Infections
GATIFLOXACIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
L4618BD7KJ
Molecule Type:
Small molecule
Molecular Formula:
C19H22FN3O4
Molecular Weight:
375.4
AlogP:
1.98
PSA:
83.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DALFOPRISTIN
(1999)
Small molecule
Bacterial 70S ribosome inhibitor
Unknown
Approved
Unknown
DALFOPRISTIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
R9M4FJE48E
Molecule Type:
Small molecule
Molecular Formula:
C34H50N4O9S
Molecular Weight:
690.86
AlogP:
2.27
PSA:
176.42
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CHOLECALCIFEROL
(1999)
Small molecule
Vitamin D receptor agonist
Unknown
Approved
Anemia; Anemia, Iron-Deficiency; Osteoporosis
CHOLECALCIFEROL
×
Maximum Phase:
4
First Approval:
1999
UNII:
1C6V77QF41
Molecule Type:
Small molecule
Molecular Formula:
C27H44O
Molecular Weight:
384.65
AlogP:
7.62
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
6.0
Source:
RAPACURONIUM
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
RAPACURONIUM
×
Maximum Phase:
4
First Approval:
1999
UNII:
GG1LBM463S
Molecule Type:
Small molecule
Molecular Formula:
C37H61N2O4+
Molecular Weight:
597.91
AlogP:
6.91
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ROSIGLITAZONE MALEATE
(1999)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
ROSIGLITAZONE MALEATE
×
Maximum Phase:
4
First Approval:
1999
UNII:
KX2339DP44
Molecule Type:
Small molecule
Molecular Formula:
C22H23N3O7S
Molecular Weight:
473.51
AlogP:
2.49
PSA:
71.53
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DOFETILIDE
(1999)
Small molecule
HERG blocker
ORAL
Approved
Arrhythmias, Cardiac; Atrial Fibrillation
DOFETILIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
R4Z9X1N2ND
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O5S2
Molecular Weight:
441.58
AlogP:
1.98
PSA:
104.81
HBD:
2.0
HBA:
#RotB:
11.0
Source:
NITRIC OXIDE
(1999)
Small molecule
Soluble guanylate cyclase activator
Unknown
Approved
Hypertension, Pulmonary; Respiratory Insufficiency; Respiratory Tract Diseases
NITRIC OXIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
31C4KY9ESH
Molecule Type:
Small molecule
Molecular Formula:
NO
Molecular Weight:
30.01
AlogP:
-0.45
PSA:
39.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
QUINUPRISTIN
(1999)
Small molecule
Bacterial 70S ribosome inhibitor
Unknown
Approved
Unknown
QUINUPRISTIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
23OW28RS7P
Molecule Type:
Small molecule
Molecular Formula:
C53H67N9O10S
Molecular Weight:
1022.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PEMIROLAST
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
PEMIROLAST
×
Maximum Phase:
4
First Approval:
1999
UNII:
2C09NV773M
Molecule Type:
Small molecule
Molecular Formula:
C10H8N6O
Molecular Weight:
228.22
AlogP:
0.18
PSA:
88.83
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DEFERIPRONE
(1999)
Small molecule
Unknown
ORAL
Approved
Anemia, Sickle Cell; Thalassemia
DEFERIPRONE
×
Maximum Phase:
4
First Approval:
1999
UNII:
2BTY8KH53L
Molecule Type:
Small molecule
Molecular Formula:
C7H9NO2
Molecular Weight:
139.15
AlogP:
0.4
PSA:
42.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ROSIGLITAZONE
(1999)
Small molecule
Unknown
Unknown
Approved
Diabetes Mellitus
ROSIGLITAZONE
×
Maximum Phase:
4
First Approval:
1999
UNII:
05V02F2KDG
Molecule Type:
Small molecule
Molecular Formula:
C18H19N3O3S
Molecular Weight:
357.44
AlogP:
2.49
PSA:
71.53
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ORLISTAT
(1999)
Small molecule
Gastric lipase inhibitor
ORAL
Approved
Obesity
ORLISTAT
×
Maximum Phase:
4
First Approval:
1999
UNII:
95M8R751W8
Molecule Type:
Small molecule
Molecular Formula:
C29H53NO5
Molecular Weight:
495.75
AlogP:
6.88
PSA:
81.7
HBD:
1.0
HBA:
#RotB:
23.0
Source:
AMPRENAVIR
(1999)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Virus Diseases
AMPRENAVIR
×
Maximum Phase:
4
First Approval:
1999
UNII:
5S0W860XNR
Molecule Type:
Small molecule
Molecular Formula:
C25H35N3O6S
Molecular Weight:
505.64
AlogP:
2.4
PSA:
131.19
HBD:
3.0
HBA:
#RotB:
11.0
Source:
DEXMEDETOMIDINE
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
DEXMEDETOMIDINE
×
Maximum Phase:
4
First Approval:
1999
UNII:
67VB76HONO
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2
Molecular Weight:
200.28
AlogP:
3.18
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ENTACAPONE
(1999)
Small molecule
Catechol O-methyltransferase inhibitor
ORAL
Approved
Parkinson Disease
ENTACAPONE
×
Maximum Phase:
4
First Approval:
1999
UNII:
4975G9NM6T
Molecule Type:
Small molecule
Molecular Formula:
C14H15N3O5
Molecular Weight:
305.29
AlogP:
1.78
PSA:
127.7
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EPIRUBICIN HYDROCHLORIDE
(1999)
Small molecule
DNA inhibitor
INJECTION; INTRAVENOUS
Approved
Breast Neoplasms; Neoplasms
EPIRUBICIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
22966TX7J5
Molecule Type:
Small molecule
Molecular Formula:
C27H30ClNO11
Molecular Weight:
579.99
AlogP:
0.0
PSA:
206.07
HBD:
6.0
HBA:
#RotB:
5.0
Source:
CAFFEINE, CITRATED
(1999)
Small molecule
Adenosine receptor antagonist
Unknown
Approved
Unknown
CAFFEINE, CITRATED
×
Maximum Phase:
4
First Approval:
1999
UNII:
U26EO4675Q
Molecule Type:
Small molecule
Molecular Formula:
C14H18N4O9
Molecular Weight:
386.32
AlogP:
-1.03
PSA:
61.82
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PYRETHRINS
(2000)
Small molecule
Voltage-sensitive sodium channel alpha-subunit blocker
Unknown
Approved
Unknown
PYRETHRINS
×
Maximum Phase:
4
First Approval:
2000
UNII:
ZUM06L90GV
Molecule Type:
Small molecule
Molecular Formula:
C43H56O8
Molecular Weight:
700.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
POLYTETRAFLUOROETHYLENE
(2000)
Small molecule
Unknown
Unknown
Approved
Unknown
POLYTETRAFLUOROETHYLENE
×
Maximum Phase:
4
First Approval:
2000
UNII:
E1NC1JVS3O
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOPINAVIR
(2000)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
Unknown
Approved
HIV Infections
LOPINAVIR
×
Maximum Phase:
4
First Approval:
2000
UNII:
2494G1JF75
Molecule Type:
Small molecule
Molecular Formula:
C37H48N4O5
Molecular Weight:
628.81
AlogP:
4.33
PSA:
120.0
HBD:
4.0
HBA:
#RotB:
15.0
Source:
RIVASTIGMINE
(2000)
Small molecule
Cholinesterases; ACHE & BCHE inhibitor
TRANSDERMAL
Approved
Alzheimer Disease; Dementia; Parkinson Disease
RIVASTIGMINE
×
Maximum Phase:
4
First Approval:
2000
UNII:
PKI06M3IW0
Molecule Type:
Small molecule
Molecular Formula:
C14H22N2O2
Molecular Weight:
250.34
AlogP:
2.76
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
4.0
Source:
OXCARBAZEPINE
(2000)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
OXCARBAZEPINE
×
Maximum Phase:
4
First Approval:
2000
UNII:
VZI5B1W380
Molecule Type:
Small molecule
Molecular Formula:
C15H12N2O2
Molecular Weight:
252.27
AlogP:
2.64
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
0.0
Source:
1
2
…
49
50
51
52
53
54
55
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA